Methyl Prednisolone (MP)

DRUG4 trials

Sponsors

Assistance Publique - Hôpitaux de Paris, Konya City Hospital, Sana'a University, University of Alabama at Birmingham

Conditions

ACL ReconstructionHemophagocytic Lymphohistiocytosis (HLH)Hyaluronic AcidMethylprednisoloneNeuromuscular Block, ResidualPain ManagementPost Operative ComplicationsPostoperative Nausea

Phase 1

Treatment of Familiar Lymphohistiocytosis

CompletedNCT02472054

Assistance Publique - Hôpitaux de ParisHemophagocytic Lymphohistiocytosis (HLH)

Start: 2015-06-29End: 2020-05-20Updated: 2026-03-30

Phase 3

Comparing Methylprednisolone And Hyaluronic Acid To Reduce Wisdom Tooth Surgery Complications

Enrolling by invitationNCT07317596

Sana'a UniversityHyaluronic Acid, Methylprednisolone, Post Operative Complications +1

Start: 2024-06-27End: 2026-07-15Target: 40Updated: 2026-04-30

Phase 4

Methylprednisolone Addition to Multimodal Pain Regimens After Anterior Cruciate Ligament Reconstruction

Not yet recruitingNCT07605923

University of Alabama at BirminghamACL Reconstruction

Start: 2026-09-01End: 2031-08-01Target: 64Updated: 2026-05-26

Unknown Phase

Methylprednisolone vs Dexamethasone Interaction With Sugammadex in Pediatric Patients

CompletedNCT07175623

Konya City HospitalNeuromuscular Block, Residual, Pain Management, Postoperative Nausea

Start: 2025-09-16End: 2025-12-20Updated: 2025-12-29

Related Papers

Alemtuzumab as First Line Treatment in Children with Familial Lymphohistiocytosis

Blood2019-11-1333 citations